Johnson & Johnson (JNJ)
155.17
-0.33
(-0.21%)
USD |
NYSE |
Nov 22, 16:00
155.39
+0.22
(+0.14%)
After-Hours: 20:00
Johnson & Johnson Market Cap: 373.59B for Nov. 22, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 22, 2024 | 373.59B |
| November 21, 2024 | 374.39B |
| November 20, 2024 | 368.63B |
| November 19, 2024 | 368.37B |
| November 18, 2024 | 372.63B |
| November 15, 2024 | 370.77B |
| November 14, 2024 | 365.65B |
| November 13, 2024 | 368.94B |
| November 12, 2024 | 367.50B |
| November 11, 2024 | 373.28B |
| November 08, 2024 | 374.31B |
| November 07, 2024 | 377.35B |
| November 06, 2024 | 380.12B |
| November 05, 2024 | 381.25B |
| November 04, 2024 | 380.98B |
| November 01, 2024 | 385.53B |
| October 31, 2024 | 384.88B |
| October 30, 2024 | 386.69B |
| October 29, 2024 | 385.44B |
| October 28, 2024 | 389.07B |
| October 25, 2024 | 387.34B |
| October 24, 2024 | 394.06B |
| October 23, 2024 | 399.33B |
| October 22, 2024 | 393.53B |
| October 21, 2024 | 392.03B |
| Date | Value |
|---|---|
| October 18, 2024 | 397.55B |
| October 17, 2024 | 395.98B |
| October 16, 2024 | 395.52B |
| October 15, 2024 | 395.04B |
| October 14, 2024 | 389.02B |
| October 11, 2024 | 388.68B |
| October 10, 2024 | 386.40B |
| October 09, 2024 | 386.73B |
| October 08, 2024 | 384.42B |
| October 07, 2024 | 384.04B |
| October 04, 2024 | 385.87B |
| October 03, 2024 | 386.37B |
| October 02, 2024 | 387.98B |
| October 01, 2024 | 389.96B |
| September 30, 2024 | 390.13B |
| September 27, 2024 | 388.53B |
| September 26, 2024 | 388.51B |
| September 25, 2024 | 386.60B |
| September 24, 2024 | 391.85B |
| September 23, 2024 | 392.91B |
| September 20, 2024 | 395.17B |
| September 19, 2024 | 396.76B |
| September 18, 2024 | 399.96B |
| September 17, 2024 | 402.18B |
| September 16, 2024 | 401.99B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
293.00B
Minimum
Mar 23 2020
489.47B
Maximum
Apr 25 2022
410.97B
Average
409.12B
Median
Market Cap Benchmarks
| Amgen Inc | 158.32B |
| Eli Lilly and Co | 710.10B |
| Merck & Co Inc | 250.89B |
| Pfizer Inc | 145.36B |
| AbbVie Inc | 312.70B |
Market Cap Related Metrics
| PE Ratio | 25.65 |
| PS Ratio | 4.296 |
| Price to Book Value | 5.325 |
| Price to Free Cash Flow | 19.80 |
| Price | 155.17 |
| Earnings Yield | 3.90% |
| Operating PE Ratio | 16.51 |
| Normalized PE Ratio | 18.19 |